4Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med, 2002,346(2 ) :92.
二级参考文献6
1Yokoyama A. Current status and future directions of gemcitabine in the treatment of non-small-cell lung cancer and pancreatic cancer.Gan To kagaku Ryoho, 2000,27(8) :1294.
2Braakhuis BJM,Van Dongen GA ,Vermorken JB ,et al. Preclinical in vivo activity gemcitabine against human head and neck cancer. Cancer Res, 1991,51(1) :211.
3Manegold C,Zatloukal P, Krejcy K, et al. Gemcitabine in non-small-cell lung cancer. Invest New Drugs, 2000,18(1) :29.
4Merimsky O, Wigler N, Greif Y, et al. Monthly gemcitabine ( days1,8 and 15 ) plus cisplatin ( days1-3 ) in advanced non-small-cell lung cancer: a phase Ⅱ study. Anticancer Drugs, 2000,11(2) :117.
5Soto parra HJ, Cancer R, Antonelli G, et al. Superioxity of three week vs four week schedule of cisplatin (CDDP) and gemcitabine (GEM) :results of a randomized phase Ⅱ study. Lung Cancer, 2000,29( supple 1 ) :48.
